CCND1 and cardiac hypertrophy: Huang et.al had found that attenuation of miR-16 could repress expression of cyclins D1, D2 and E1, and activate cyclin/Rb pathway to induce the cardiomyocyte hypertrophy, revealing that miR-16 might be a target to manage cardiac hypertrophy [20].